Discussion  by unknown
JOURNAL OF VASCULAR SURGERY
480 Sgroi et al February 2015outcome and long-term survival in 136 patients. Ann Surg 2008;247:
300-9.
22. Leach SD, Lee JE, Charnsangavej C, Cleary KR, Lowy AM,
Fenoglio CJ, et al. Survival following pancreaticoduodenectomy with
resection of the superior mesentericeportal vein conﬂuence for
adenocarcinoma of the pancreatic head. Br J Surg 1998;85:611-7.
23. Martin RC 2nd, Scoggins CR, Egnatashvili V, Staley CA,
McMasters KM, Kooby DA. Arterial and venous resection for
pancreatic adenocarcinoma: operative and long-term outcomes. Arch
Surg 2009;144:154-9.
24. Gong Y, Zhang L, He T, Ding J, Zhang H, Chen G, et al. Pan-
creaticoduodenectomy combined with vascular resection and recon-
struction for patients with locally advanced pancreatic cancer: a
multicenter, retrospective analysis. PLoS One 2013;8:e70340.
25. Evans DB, Farnell MB, Lillemoe KD, Vollmer C Jr, Strasberg SM,
Schulick RD. Surgical treatment of resectable and borderline resectable
pancreas cancer: expert consensus statement. Ann Surg Oncol
2009;16:1736-44.26. Marangoni G, O’Sullivan A, Faraj W, Heaton N, Rela M. Pancrea-
tectomy with synchronous vascular resectiondan argument in favour.
Surgeon 2012;10:102-6.
27. Chu CK, Farnell MB, Nguyen JH, Stauffer JA, Kooby DA,
Sclabas GM, et al. Prosthetic graft reconstruction after portal vein
resection in pancreaticoduodenectomy: a multicenter analysis. J Am
Coll Surg 2010;211:316-24.
28. Amano H, Miura F, Toyota N, Wada K, Katoh K, Hayano K, et al. Is
pancreatectomy with arterial reconstruction a safe and useful procedure
for locally advanced pancreatic cancer? J Hepatobiliary Pancreat Surg
2009;16:850-7.
29. Turley RS, Peterson K, Barbas AS, Ceppa EP, Paulson EK,
Blazer DG 3rd, et al. Vascular surgery collaboration during pan-
creaticoduodenectomy with vascular reconstruction. Ann Vasc Surg
2012;26:685-92.Submitted Jun 10, 2014; accepted Sep 5, 2014.DISCUSSIONDr Peter Lawrence (Los Angeles, Calif). I assume that most
of your patients get preoperative imaging with computed tomog-
raphy (CT)/computed tomography angiography or magnetic
resonance imaging/magnetic resonance angiography. Tell us
what the appropriate cross-sectional imaging workup is preopera-
tively, to look at vascular anatomy. Should every patient who is a
candidate for a Whipple have one of those imaging studies?
Dr Michael Sgroi. At our institution, every patient does
receive a triphasic CT scan, allowing the vascularity as well as tu-
mor involvement to be recognized. When possible, because the
vascular surgery service within our university performs all of the
operations, they are given these images preoperatively. So it is
our recommendation that all patients receive imaging.
Dr John Blebea (Tulsa, Okla). Can you tell us more about
the outcomes of these vascular reconstructions and their patency?
Were they followed postoperatively, and if so, using what
modalitydultrasound or CT scanning in conjunction with their
cancer follow-up?
Dr Sgroi. All patients did receive a duplex to evaluate for por-
tal vein thrombosis or arterial thrombosis postoperatively within
the vascular group. In addition to that, the hepatobiliary service
also would have regular CT scans to evaluate for any recurrence,
particularly in T3 lesions because it is elevated.
In addition to that, with the complications, we did have an
11.6% portal vein thrombosis rate, three of which were in the acute
setting and four that were delayed. Two of the three that occurred
in the acute setting were part of our 30-day mortality. With the
ones that had delayed thrombosis, those actually had survival
that was equivalent to the rest of our vascular reconstruction
group.
Dr Hasan Dosluoglu (Buffalo, NY). One question is that
years ago, I think, that the Hopkins group already showed that
when you try to resect these for cure, yet you leave a positive
microscopic margin behind, the patients still do better than just
leaving it alone.
Now, what you don’t have here are the patients that
you backed out without resection, and how they compared tothose with positive margins after this aggressive vascular
reconstruction.
When you group all patients having positive and negative mar-
gins together, it dilutes the data. What we’re really looking for is,
after all that effort, was it all worth it, when you did all that and still
had positive margins; and it may have been the case.
Dr Sgroi. Thank you for that question and actually that
brings up a great point. For these types of cases, it’s been proven
in the literature that palliative care for T3 lesions that have vascular
involvement is approximately 10 months. So we’re giving about an
80% increase in their overall survival. So we do believe even with
that R1 resection that this is a good procedure to perform.
Dr Rabih Chaer (Pittsburgh, Pa). We’re oftentimes asked to
harvest the jugular vein with a facial vein pedicle in order to perfuse
the splenic vein, in addition to the portal vein. Do you think this
has any advantage in terms of graft patency or cancer survival?
Dr Sgroi. We were actually very liberal about ligating the
splenic vein. If they had sinistral hypertension, then obviously we
would do our best not to. But we found that we were able to
get more length during our dissection and be able to perform a pri-
mary repair, so we actually did quite a bit of just ligation of that
splenic vein.
Dr William Quinones-Baldrich (Los Angeles, Calif). I think
it is critical that vascular surgery be involved prior to the procedure
as it is much more difﬁcult to decide the best alternative when one
is called during the operation. It is best to have a team that is dedi-
cated to evaluate and plan these complex procedures. My question
is: How many of these cases were you asked to evaluate preopera-
tively? How often were you called in the middle of the procedure?
Dr Sgroi. Thank you for your comment and your question.
We agree with you that if preoperatively the vascular surgeons
can know, that was attempted. I can tell you from reading the
operative reports that the only ones I can recognize for which
we were not called were the superior mesenteric artery involve-
ment, because those were ones that if that was found preopera-
tively, the resection wouldn’t have actually been done. So in
general we were always told prior to going to the operating room.
